ArticleInfectious diseases and therapy2023

Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve, Compensated Cirrhotic HCV Patients.

Nancy Reau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.